About
Medinol is dedicated to the science of cardiovascular intervention. Medinol develops, manufactures, and markets EluNIR, an elastomeric drug-eluting stent made from a thin cobalt-chrome alloy and recognized for its optimal balance between flexibility, conformability, scaffolding, and low metal footprint. EluNIR offers a new level of uniform drug elution and surface quality and demonstrated excellent clinical outcomes and long-term safety profile in clinical studies. EluNIR features the novel Flexx catheter technology with a visible metallic spring tip that eliminates tip flare-out and buckling. Flexx overcomes standard polymer tip limitations, offering both superb flexibility and uncompromised crossability, resulting in unprecedented ease of delivery even in complex anatomies.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Medinol's primary focus in the medical field?
- Medinol is dedicated to the science of cardiovascular intervention, developing, manufacturing, and marketing medical devices like the EluNIR drug-eluting stent.
- What is the key product developed by Medinol?
- Medinol's key product is EluNIR, an elastomeric drug-eluting stent made from a thin cobalt-chrome alloy, designed for cardiovascular intervention.
- When was Medinol founded?
- Medinol was founded in December 1992.
- Where are Medinol's headquarters located?
- Medinol's headquarters are located in Jerusalem, Israel.
- Does Medinol have offices outside of Israel?
- Yes, Medinol has an office in Colorado Springs, USA, in addition to its offices in Jerusalem and Tel Aviv-Yafo, Israel.
- What was a significant regulatory approval for Medinol's EluNIR stent in late 2017?
- In November 2017, Cordis and Medinol announced FDA approval of the EluNIR Drug-Eluting Stent System, following European clearance in October 2017.
- When did Medinol's EluNIR drug-eluting stent first see commercial implants in the U.S.?
- In January 2018, Cordis and Medinol announced the first U.S. commercial implants of the EluNIR™ Drug-Eluting Stent.
- How many employees does Medinol currently have?
- Medinol has between 51 and 200 employees, with an exact count of 137 employees.
- What was the finding of a study regarding Medinol's stent performance in January 2020?
- In January 2020, a study indicated that Medinol's stent performed as well as the Medtronic Resolute stent.